APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Radiopharmaceuticals

Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.

Selected research

Market Outlook & Growth Opportunities

Global Radiopharmaceuticals Market Outlook and Growth Opportunities 2026

Report ID 17403065042 January 2026196 pages

Choose your research edition.

Industry ResearchRadiopharmaceuticals Industry Research Report 2026137 pages · $2,950 USDIndustry Growth & TrendsGlobal Radiopharmaceuticals Industry Growth and Trends Forecast to 2032117 pages · $3,450 USDMarket StructureGlobal Radiopharmaceuticals Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Radiopharmaceuticals Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Radiopharmaceuticals Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.

The major players in global Radiopharmaceuticals market include Bracco Imaging, Bayer, Mallinckrodt, etc. The top 3 players hold over 40% of global market shares. North America and Europe are main markets, they occupy over 70% of the global market. Diagnostic Radioisotopes is the main type, with a share about 90%. Oncology is the key application, which hold over 60% shares.

This report provides an overview of the global Radiopharmaceuticals market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Radiopharmaceuticals and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Radiopharmaceuticals sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Radiopharmaceuticals market size, projected growth trends, production technologies, key applications, and end-use industries.

Radiopharmaceuticals Segment by Company

Bracco Imaging

Bayer

Mallinckrodt

Nordion

Triad Isotopes

Lantheus

IBA Group

GE Healthcare

China Isotope & Radiation

Jubilant Pharma

Eli Lilly

Advanced Accelerator Applications

SIEMENS

Dongcheng

Navidea

Radiopharmaceuticals Segment by Type

Diagnostic Radioisotopes

Therapeutic Radioisotopes

Radiopharmaceuticals Segment by Application

Oncology

Cardiology

Other

Radiopharmaceuticals Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Radiopharmaceuticals status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Radiopharmaceuticals market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Radiopharmaceuticals significant trends, drivers, influence factors in global and regions.

6. To analyze Radiopharmaceuticals competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Radiopharmaceuticals market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Radiopharmaceuticals and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Radiopharmaceuticals.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Radiopharmaceuticals market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Radiopharmaceuticals industry.

Chapter 3: Detailed analysis of Radiopharmaceuticals manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Radiopharmaceuticals in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Radiopharmaceuticals in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Radiopharmaceuticals Industry Trends Table 2. Radiopharmaceuticals Industry Drivers Table 3. Radiopharmaceuticals Industry Opportunities and Challenges Table 4. Radiopharmaceuticals Industry Restraints Table 5. Global Radiopharmaceuticals Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Radiopharmaceuticals Revenue Share by Company (2021-2026) Table 7. Global Radiopharmaceuticals Sales Volume by Company (K Dose) & (2021-2026) Table 8. Global Radiopharmaceuticals Sales Volume Share by Company (2021-2026) Table 9. Global Radiopharmaceuticals Average Price (US$/Dose) of Company (2021-2026) Table 10. Global Radiopharmaceuticals Company Ranking, (2024-2026) & (USD Million) Table 11. Global Radiopharmaceuticals Key Company Manufacturing Base & Headquarters Table 12. Global Radiopharmaceuticals Company, Product Type & Application Table 13. Global Radiopharmaceuticals Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Radiopharmaceuticals by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Diagnostic Radioisotopes Table 18. Significant Companies of Therapeutic Radioisotopes Table 19. Global Radiopharmaceuticals Sales Volume by Type 2021 VS 2025 VS 2032 (K Dose) Table 20. Global Radiopharmaceuticals Sales Volume by Type (2021-2026) & (K Dose) Table 21. Global Radiopharmaceuticals Sales Volume by Type (2027-2032) & (K Dose) Table 22. Global Radiopharmaceuticals Sales Volume Share by Type (2021-2026) Table 23. Global Radiopharmaceuticals Sales Volume Share by Type (2027-2032) Table 24. Global Radiopharmaceuticals Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Radiopharmaceuticals Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Radiopharmaceuticals Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Radiopharmaceuticals Sales Value Share by Type (2021-2026) Table 28. Global Radiopharmaceuticals Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Oncology Table 30. Significant Companies of Cardiology Table 31. Significant Companies of Other Table 32. Global Radiopharmaceuticals Sales Volume by Application 2021 VS 2025 VS 2032 (K Dose) Table 33. Global Radiopharmaceuticals Sales Volume by Application (2021-2026) & (K Dose) Table 34. Global Radiopharmaceuticals Sales Volume by Application (2027-2032) & (K Dose) Table 35. Global Radiopharmaceuticals Sales Volume Share by Application (2021-2026) Table 36. Global Radiopharmaceuticals Sales Volume Share by Application (2027-2032) Table 37. Global Radiopharmaceuticals Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Radiopharmaceuticals Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Radiopharmaceuticals Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Radiopharmaceuticals Sales Value Share by Application (2021-2026) Table 41. Global Radiopharmaceuticals Sales Value Share by Application (2027-2032) Table 42. Global Radiopharmaceuticals Sales by Region: 2021 VS 2025 VS 2032 (K Dose) Table 43. Global Radiopharmaceuticals Sales by Region (2021-2026) & (K Dose) Table 44. Global Radiopharmaceuticals Sales Market Share by Region (2021-2026) Table 45. Global Radiopharmaceuticals Sales by Region (2027-2032) & (K Dose) Table 46. Global Radiopharmaceuticals Sales Market Share by Region (2027-2032) Table 47. Global Radiopharmaceuticals Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Radiopharmaceuticals Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Radiopharmaceuticals Sales Value Share by Region (2021-2026) Table 50. Global Radiopharmaceuticals Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Radiopharmaceuticals Sales Value Share by Region (2027-2032) Table 52. Global Radiopharmaceuticals Market Average Price (US$/Dose) by Region (2021-2026) Table 53. Global Radiopharmaceuticals Market Average Price (US$/Dose) by Region (2027-2032) Table 54. Global Radiopharmaceuticals Sales by Country: 2021 VS 2025 VS 2032 (K Dose) Table 55. Global Radiopharmaceuticals Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Radiopharmaceuticals Sales by Country (2021-2026) & (K Dose) Table 57. Global Radiopharmaceuticals Sales Market Share by Country (2021-2026) Table 58. Global Radiopharmaceuticals Sales by Country (2027-2032) & (K Dose) Table 59. Global Radiopharmaceuticals Sales Market Share by Country (2027-2032) Table 60. Global Radiopharmaceuticals Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Radiopharmaceuticals Sales Value Market Share by Country (2021-2026) Table 62. Global Radiopharmaceuticals Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Radiopharmaceuticals Sales Value Market Share by Country (2027-2032) Table 64. Bracco Imaging Company Information Table 65. Bracco Imaging Business Overview Table 66. Bracco Imaging Radiopharmaceuticals Sales (K Dose), Value (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 67. Bracco Imaging Radiopharmaceuticals Product Portfolio Table 68. Bracco Imaging Recent Development Table 69. Bayer Company Information Table 70. Bayer Business Overview Table 71. Bayer Radiopharmaceuticals Sales (K Dose), Value (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 72. Bayer Radiopharmaceuticals Product Portfolio Table 73. Bayer Recent Development Table 74. Mallinckrodt Company Information Table 75. Mallinckrodt Business Overview Table 76. Mallinckrodt Radiopharmaceuticals Sales (K Dose), Value (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 77. Mallinckrodt Radiopharmaceuticals Product Portfolio Table 78. Mallinckrodt Recent Development Table 79. Nordion Company Information Table 80. Nordion Business Overview Table 81. Nordion Radiopharmaceuticals Sales (K Dose), Value (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 82. Nordion Radiopharmaceuticals Product Portfolio Table 83. Nordion Recent Development Table 84. Triad Isotopes Company Information Table 85. Triad Isotopes Business Overview Table 86. Triad Isotopes Radiopharmaceuticals Sales (K Dose), Value (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 87. Triad Isotopes Radiopharmaceuticals Product Portfolio Table 88. Triad Isotopes Recent Development Table 89. Lantheus Company Information Table 90. Lantheus Business Overview Table 91. Lantheus Radiopharmaceuticals Sales (K Dose), Value (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 92. Lantheus Radiopharmaceuticals Product Portfolio Table 93. Lantheus Recent Development Table 94. IBA Group Company Information Table 95. IBA Group Business Overview Table 96. IBA Group Radiopharmaceuticals Sales (K Dose), Value (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 97. IBA Group Radiopharmaceuticals Product Portfolio Table 98. IBA Group Recent Development Table 99. GE Healthcare Company Information Table 100. GE Healthcare Business Overview Table 101. GE Healthcare Radiopharmaceuticals Sales (K Dose), Value (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 102. GE Healthcare Radiopharmaceuticals Product Portfolio Table 103. GE Healthcare Recent Development Table 104. China Isotope & Radiation Company Information Table 105. China Isotope & Radiation Business Overview Table 106. China Isotope & Radiation Radiopharmaceuticals Sales (K Dose), Value (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 107. China Isotope & Radiation Radiopharmaceuticals Product Portfolio Table 108. China Isotope & Radiation Recent Development Table 109. Jubilant Pharma Company Information Table 110. Jubilant Pharma Business Overview Table 111. Jubilant Pharma Radiopharmaceuticals Sales (K Dose), Value (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 112. Jubilant Pharma Radiopharmaceuticals Product Portfolio Table 113. Jubilant Pharma Recent Development Table 114. Eli Lilly Company Information Table 115. Eli Lilly Business Overview Table 116. Eli Lilly Radiopharmaceuticals Sales (K Dose), Value (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 117. Eli Lilly Radiopharmaceuticals Product Portfolio Table 118. Eli Lilly Recent Development Table 119. Advanced Accelerator Applications Company Information Table 120. Advanced Accelerator Applications Business Overview Table 121. Advanced Accelerator Applications Radiopharmaceuticals Sales (K Dose), Value (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 122. Advanced Accelerator Applications Radiopharmaceuticals Product Portfolio Table 123. Advanced Accelerator Applications Recent Development Table 124. SIEMENS Company Information Table 125. SIEMENS Business Overview Table 126. SIEMENS Radiopharmaceuticals Sales (K Dose), Value (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 127. SIEMENS Radiopharmaceuticals Product Portfolio Table 128. SIEMENS Recent Development Table 129. Dongcheng Company Information Table 130. Dongcheng Business Overview Table 131. Dongcheng Radiopharmaceuticals Sales (K Dose), Value (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 132. Dongcheng Radiopharmaceuticals Product Portfolio Table 133. Dongcheng Recent Development Table 134. Navidea Company Information Table 135. Navidea Business Overview Table 136. Navidea Radiopharmaceuticals Sales (K Dose), Value (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 137. Navidea Radiopharmaceuticals Product Portfolio Table 138. Navidea Recent Development Table 139. Key Raw Materials Table 140. Raw Materials Key Suppliers Table 141. Radiopharmaceuticals Distributors List Table 142. Radiopharmaceuticals Customers List Table 143. Research Programs/Design for This Report Table 144. Authors List of This Report Table 145. Secondary Sources Table 146. Primary Sources List of Figures Figure 1. Radiopharmaceuticals Product Image Figure 2. Global Radiopharmaceuticals Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Radiopharmaceuticals Sales Value (2021-2032) & (US$ Million) Figure 4. Global Radiopharmaceuticals Sales (2021-2032) & (K Dose) Figure 5. Global Radiopharmaceuticals Sales Average Price (US$/Dose) & (2021-2032) Figure 6. Global Radiopharmaceuticals Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Diagnostic Radioisotopes Image Figure 10. Therapeutic Radioisotopes Image Figure 11. Global Radiopharmaceuticals Sales Volume by Type (2021 VS 2025 VS 2032) & (K Dose) Figure 12. Global Radiopharmaceuticals Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Radiopharmaceuticals Sales Volume Share by Type (2021-2032) Figure 14. Global Radiopharmaceuticals Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Radiopharmaceuticals Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Radiopharmaceuticals Sales Value Share by Type (2021-2032) Figure 17. Oncology Image Figure 18. Cardiology Image Figure 19. Other Image Figure 20. Global Radiopharmaceuticals Sales Volume by Application (2021 VS 2025 VS 2032) & (K Dose) Figure 21. Global Radiopharmaceuticals Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Radiopharmaceuticals Sales Volume Share by Application (2021-2032) Figure 23. Global Radiopharmaceuticals Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Radiopharmaceuticals Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Radiopharmaceuticals Sales Value Share by Application (2021-2032) Figure 26. Global Radiopharmaceuticals Sales by Region: 2021 VS 2025 VS 2032 (K Dose) Figure 27. Global Radiopharmaceuticals Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Radiopharmaceuticals Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Radiopharmaceuticals Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Radiopharmaceuticals Sales Value (2021-2032) & (US$ Million) Figure 31. North America Radiopharmaceuticals Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Radiopharmaceuticals Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Radiopharmaceuticals Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Radiopharmaceuticals Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Radiopharmaceuticals Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Radiopharmaceuticals Sales Value (2021-2032) & (US$ Million) Figure 37. South America Radiopharmaceuticals Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Radiopharmaceuticals Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Radiopharmaceuticals Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Radiopharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Radiopharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Radiopharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Radiopharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Radiopharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Radiopharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Radiopharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Radiopharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Radiopharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Radiopharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Radiopharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Radiopharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Radiopharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Radiopharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Radiopharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Radiopharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Radiopharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Radiopharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Radiopharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Radiopharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Radiopharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Radiopharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Radiopharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Radiopharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Radiopharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Radiopharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Radiopharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Radiopharmaceuticals Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Radiopharmaceuticals Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Radiopharmaceuticals Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Diagnostic Radioisotopes
  • Therapeutic Radioisotopes
Applications
  • Oncology
  • Cardiology
  • Other
Companies covered
  • Bracco Imaging
  • Bayer
  • Mallinckrodt
  • Nordion
  • Triad Isotopes
  • Lantheus
  • IBA Group
  • GE Healthcare
  • China Isotope & Radiation
  • Jubilant Pharma
  • Eli Lilly
  • Advanced Accelerator Applications
  • SIEMENS
  • Dongcheng
  • Navidea

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Radiopharmaceuticals Sales Value (2021-2032)
  4. 1.2.2 Global Radiopharmaceuticals Sales Volume (2021-2032)
  5. 1.2.3 Global Radiopharmaceuticals Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Radiopharmaceuticals Market Dynamics
  1. 2.1 Radiopharmaceuticals Industry Trends
  2. 2.2 Radiopharmaceuticals Industry Drivers
  3. 2.3 Radiopharmaceuticals Industry Opportunities and Challenges
  4. 2.4 Radiopharmaceuticals Industry Restraints
3 Radiopharmaceuticals Market by Company
  1. 3.1 Global Radiopharmaceuticals Company Revenue Ranking in 2025
  2. 3.2 Global Radiopharmaceuticals Revenue by Company (2021-2026)
  3. 3.3 Global Radiopharmaceuticals Sales Volume by Company (2021-2026)
  4. 3.4 Global Radiopharmaceuticals Average Price by Company (2021-2026)
  5. 3.5 Global Radiopharmaceuticals Company Ranking (2024-2026)
  6. 3.6 Global Radiopharmaceuticals Company Manufacturing Base and Headquarters
  7. 3.7 Global Radiopharmaceuticals Company Product Type and Application
  8. 3.8 Global Radiopharmaceuticals Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Radiopharmaceuticals Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Radiopharmaceuticals Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Radiopharmaceuticals Market by Type
  1. 4.1 Radiopharmaceuticals Type Introduction
  2. 4.1.1 Diagnostic Radioisotopes
  3. 4.1.2 Therapeutic Radioisotopes
  4. 4.2 Global Radiopharmaceuticals Sales Volume by Type
  5. 4.2.1 Global Radiopharmaceuticals Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Radiopharmaceuticals Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Radiopharmaceuticals Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Radiopharmaceuticals Sales Value by Type
  9. 4.3.1 Global Radiopharmaceuticals Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Radiopharmaceuticals Sales Value by Type (2021-2032)
  11. 4.3.3 Global Radiopharmaceuticals Sales Value Share by Type (2021-2032)
5 Radiopharmaceuticals Market by Application
  1. 5.1 Radiopharmaceuticals Application Introduction
  2. 5.1.1 Oncology
  3. 5.1.2 Cardiology
  4. 5.1.3 Other
  5. 5.2 Global Radiopharmaceuticals Sales Volume by Application
  6. 5.2.1 Global Radiopharmaceuticals Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Radiopharmaceuticals Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Radiopharmaceuticals Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Radiopharmaceuticals Sales Value by Application
  10. 5.3.1 Global Radiopharmaceuticals Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Radiopharmaceuticals Sales Value by Application (2021-2032)
  12. 5.3.3 Global Radiopharmaceuticals Sales Value Share by Application (2021-2032)
6 Radiopharmaceuticals Regional Sales and Value Analysis
  1. 6.1 Global Radiopharmaceuticals Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Radiopharmaceuticals Sales by Region (2021-2032)
  3. 6.2.1 Global Radiopharmaceuticals Sales by Region: 2021-2026
  4. 6.2.2 Global Radiopharmaceuticals Sales by Region (2027-2032)
  5. 6.3 Global Radiopharmaceuticals Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Radiopharmaceuticals Sales Value by Region (2021-2032)
  7. 6.4.1 Global Radiopharmaceuticals Sales Value by Region: 2021-2026
  8. 6.4.2 Global Radiopharmaceuticals Sales Value by Region (2027-2032)
  9. 6.5 Global Radiopharmaceuticals Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Radiopharmaceuticals Sales Value (2021-2032)
  12. 6.6.2 North America Radiopharmaceuticals Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Radiopharmaceuticals Sales Value (2021-2032)
  15. 6.7.2 Europe Radiopharmaceuticals Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Radiopharmaceuticals Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Radiopharmaceuticals Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Radiopharmaceuticals Sales Value (2021-2032)
  21. 6.9.2 South America Radiopharmaceuticals Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Radiopharmaceuticals Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Radiopharmaceuticals Sales Value Share by Country, 2025 VS 2032
7 Radiopharmaceuticals Country-level Sales and Value Analysis
  1. 7.1 Global Radiopharmaceuticals Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Radiopharmaceuticals Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Radiopharmaceuticals Sales by Country (2021-2032)
  4. 7.3.1 Global Radiopharmaceuticals Sales by Country (2021-2026)
  5. 7.3.2 Global Radiopharmaceuticals Sales by Country (2027-2032)
  6. 7.4 Global Radiopharmaceuticals Sales Value by Country (2021-2032)
  7. 7.4.1 Global Radiopharmaceuticals Sales Value by Country (2021-2026)
  8. 7.4.2 Global Radiopharmaceuticals Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Radiopharmaceuticals Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Radiopharmaceuticals Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Radiopharmaceuticals Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Radiopharmaceuticals Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Radiopharmaceuticals Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Radiopharmaceuticals Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Radiopharmaceuticals Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Radiopharmaceuticals Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Radiopharmaceuticals Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Radiopharmaceuticals Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Radiopharmaceuticals Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Radiopharmaceuticals Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Radiopharmaceuticals Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Radiopharmaceuticals Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Radiopharmaceuticals Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Radiopharmaceuticals Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Radiopharmaceuticals Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Radiopharmaceuticals Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Radiopharmaceuticals Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Radiopharmaceuticals Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Radiopharmaceuticals Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Radiopharmaceuticals Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Radiopharmaceuticals Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Radiopharmaceuticals Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Radiopharmaceuticals Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Radiopharmaceuticals Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Radiopharmaceuticals Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Radiopharmaceuticals Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Radiopharmaceuticals Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Radiopharmaceuticals Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Bracco Imaging
  2. 8.1.1 Bracco Imaging Company Information
  3. 8.1.2 Bracco Imaging Business Overview
  4. 8.1.3 Bracco Imaging Radiopharmaceuticals Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Bracco Imaging Radiopharmaceuticals Product Portfolio
  6. 8.1.5 Bracco Imaging Recent Developments
  7. 8.2 Bayer
  8. 8.2.1 Bayer Company Information
  9. 8.2.2 Bayer Business Overview
  10. 8.2.3 Bayer Radiopharmaceuticals Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Bayer Radiopharmaceuticals Product Portfolio
  12. 8.2.5 Bayer Recent Developments
  13. 8.3 Mallinckrodt
  14. 8.3.1 Mallinckrodt Company Information
  15. 8.3.2 Mallinckrodt Business Overview
  16. 8.3.3 Mallinckrodt Radiopharmaceuticals Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Mallinckrodt Radiopharmaceuticals Product Portfolio
  18. 8.3.5 Mallinckrodt Recent Developments
  19. 8.4 Nordion
  20. 8.4.1 Nordion Company Information
  21. 8.4.2 Nordion Business Overview
  22. 8.4.3 Nordion Radiopharmaceuticals Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Nordion Radiopharmaceuticals Product Portfolio
  24. 8.4.5 Nordion Recent Developments
  25. 8.5 Triad Isotopes
  26. 8.5.1 Triad Isotopes Company Information
  27. 8.5.2 Triad Isotopes Business Overview
  28. 8.5.3 Triad Isotopes Radiopharmaceuticals Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Triad Isotopes Radiopharmaceuticals Product Portfolio
  30. 8.5.5 Triad Isotopes Recent Developments
  31. 8.6 Lantheus
  32. 8.6.1 Lantheus Company Information
  33. 8.6.2 Lantheus Business Overview
  34. 8.6.3 Lantheus Radiopharmaceuticals Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Lantheus Radiopharmaceuticals Product Portfolio
  36. 8.6.5 Lantheus Recent Developments
  37. 8.7 IBA Group
  38. 8.7.1 IBA Group Company Information
  39. 8.7.2 IBA Group Business Overview
  40. 8.7.3 IBA Group Radiopharmaceuticals Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 IBA Group Radiopharmaceuticals Product Portfolio
  42. 8.7.5 IBA Group Recent Developments
  43. 8.8 GE Healthcare
  44. 8.8.1 GE Healthcare Company Information
  45. 8.8.2 GE Healthcare Business Overview
  46. 8.8.3 GE Healthcare Radiopharmaceuticals Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 GE Healthcare Radiopharmaceuticals Product Portfolio
  48. 8.8.5 GE Healthcare Recent Developments
  49. 8.9 China Isotope & Radiation
  50. 8.9.1 China Isotope & Radiation Company Information
  51. 8.9.2 China Isotope & Radiation Business Overview
  52. 8.9.3 China Isotope & Radiation Radiopharmaceuticals Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 China Isotope & Radiation Radiopharmaceuticals Product Portfolio
  54. 8.9.5 China Isotope & Radiation Recent Developments
  55. 8.10 Jubilant Pharma
  56. 8.10.1 Jubilant Pharma Company Information
  57. 8.10.2 Jubilant Pharma Business Overview
  58. 8.10.3 Jubilant Pharma Radiopharmaceuticals Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Jubilant Pharma Radiopharmaceuticals Product Portfolio
  60. 8.10.5 Jubilant Pharma Recent Developments
  61. 8.11 Eli Lilly
  62. 8.11.1 Eli Lilly Company Information
  63. 8.11.2 Eli Lilly Business Overview
  64. 8.11.3 Eli Lilly Radiopharmaceuticals Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Eli Lilly Radiopharmaceuticals Product Portfolio
  66. 8.11.5 Eli Lilly Recent Developments
  67. 8.12 Advanced Accelerator Applications
  68. 8.12.1 Advanced Accelerator Applications Company Information
  69. 8.12.2 Advanced Accelerator Applications Business Overview
  70. 8.12.3 Advanced Accelerator Applications Radiopharmaceuticals Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Advanced Accelerator Applications Radiopharmaceuticals Product Portfolio
  72. 8.12.5 Advanced Accelerator Applications Recent Developments
  73. 8.13 SIEMENS
  74. 8.13.1 SIEMENS Company Information
  75. 8.13.2 SIEMENS Business Overview
  76. 8.13.3 SIEMENS Radiopharmaceuticals Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 SIEMENS Radiopharmaceuticals Product Portfolio
  78. 8.13.5 SIEMENS Recent Developments
  79. 8.14 Dongcheng
  80. 8.14.1 Dongcheng Company Information
  81. 8.14.2 Dongcheng Business Overview
  82. 8.14.3 Dongcheng Radiopharmaceuticals Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Dongcheng Radiopharmaceuticals Product Portfolio
  84. 8.14.5 Dongcheng Recent Developments
  85. 8.15 Navidea
  86. 8.15.1 Navidea Company Information
  87. 8.15.2 Navidea Business Overview
  88. 8.15.3 Navidea Radiopharmaceuticals Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Navidea Radiopharmaceuticals Product Portfolio
  90. 8.15.5 Navidea Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Radiopharmaceuticals Value Chain Analysis
  2. 9.1.1 Radiopharmaceuticals Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Radiopharmaceuticals Sales Mode & Process
  6. 9.2 Radiopharmaceuticals Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Radiopharmaceuticals Distributors
  9. 9.2.3 Radiopharmaceuticals Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst